PHASE 2 TRIAL TO EVALUATE THE EARLY BACTERICIDAL ACTIVITY, SAFETY AND TOLERABILITY OF MEROPENEM PLUS AMOXYCILLIN/CA AND FAROPENEM PLUS AMOXYCILLIN/CA IN ADULT PATIENTS WITH NEWLY DIAGNOSED PULMONARY TUBERCULOSIS: